Do analysts recommend RKDA or KO?

CocaCola has a consensus target price of $96.18, indicating a potential upside of 12.38%. Given CocaCola's stronger consensus rating and higher probable upside, analysts plainly believe CocaCola is more favorable than Arcadia Biosciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Arcadia Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 CocaCola 0 Sell rating(s) 2 Hold rating(s) 20 Buy rating(s) 1 Strong Buy rating(s) 2.96

Does the media favor RKDA or KO?

In the previous week, CocaCola had 39 more articles in the media than Arcadia Biosciences. MarketBeat recorded 40 mentions for CocaCola and 1 mentions for Arcadia Biosciences. Arcadia Biosciences' average media sentiment score of 0.49 beat CocaCola's score of 0.32 indicating that Arcadia Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Arcadia Biosciences 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CocaCola 11 Very Positive mention(s) 10 Positive mention(s) 10 Neutral mention(s) 4 Negative mention(s) 3 Very Negative mention(s) Neutral

Do analysts rate KOF or RKDA?

Coca Cola Femsa currently has a consensus target price of $118.83, indicating a potential upside of 11.48%. Given Coca Cola Femsa's stronger consensus rating and higher possible upside, research analysts plainly believe Coca Cola Femsa is more favorable than Arcadia Biosciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Coca Cola Femsa 0 Sell rating(s) 5 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.44 Arcadia Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media refer more to KOF or RKDA?

In the previous week, Coca Cola Femsa had 3 more articles in the media than Arcadia Biosciences. MarketBeat recorded 4 mentions for Coca Cola Femsa and 1 mentions for Arcadia Biosciences. Arcadia Biosciences' average media sentiment score of 0.49 beat Coca Cola Femsa's score of -0.02 indicating that Arcadia Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Coca Cola Femsa 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Arcadia Biosciences 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend RKDA or PEP?

PepsiCo has a consensus price target of $151.00, indicating a potential upside of 19.95%. Given PepsiCo's stronger consensus rating and higher probable upside, analysts plainly believe PepsiCo is more favorable than Arcadia Biosciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Arcadia Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 PepsiCo 1 Sell rating(s) 14 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.20

Is RKDA or PEP more profitable?

PepsiCo has a net margin of 10.78% compared to Arcadia Biosciences' net margin of -234.53%. PepsiCo's return on equity of 54.63% beat Arcadia Biosciences' return on equity. Company Net Margins Return on Equity Return on Assets Arcadia Biosciences -234.53% -183.50% -91.25% PepsiCo 10.78% 54.63% 10.49%

Does the media refer more to RKDA or PEP?

In the previous week, PepsiCo had 68 more articles in the media than Arcadia Biosciences. MarketBeat recorded 69 mentions for PepsiCo and 1 mentions for Arcadia Biosciences. Arcadia Biosciences' average media sentiment score of 0.49 beat PepsiCo's score of 0.01 indicating that Arcadia Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Arcadia Biosciences 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral PepsiCo 22 Very Positive mention(s) 8 Positive mention(s) 16 Neutral mention(s) 14 Negative mention(s) 6 Very Negative mention(s) Neutral

Do analysts prefer MNST or RKDA?

Monster Beverage currently has a consensus target price of $50.33, indicating a potential upside of 17.20%. Given Monster Beverage's stronger consensus rating and higher probable upside, analysts clearly believe Monster Beverage is more favorable than Arcadia Biosciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Monster Beverage 0 Sell rating(s) 9 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 2.59 Arcadia Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media refer more to MNST or RKDA?

In the previous week, Monster Beverage had 8 more articles in the media than Arcadia Biosciences. MarketBeat recorded 9 mentions for Monster Beverage and 1 mentions for Arcadia Biosciences. Arcadia Biosciences' average media sentiment score of 0.49 beat Monster Beverage's score of 0.40 indicating that Arcadia Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Monster Beverage 3 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Arcadia Biosciences 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer RKDA or CCEP?

Coca-Cola Europacific Partners has a consensus price target of $108.44, indicating a potential upside of 7.31%. Given Coca-Cola Europacific Partners' stronger consensus rating and higher possible upside, analysts clearly believe Coca-Cola Europacific Partners is more favorable than Arcadia Biosciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Arcadia Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Coca-Cola Europacific Partners 1 Sell rating(s) 3 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.64

Which has preferable earnings & valuation, RKDA or CCEP?

Coca-Cola Europacific Partners has higher revenue and earnings than Arcadia Biosciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Arcadia Biosciences $4.75M 0.15 -$2.34M -$4.56 N/A Coca-Cola Europacific Partners $23.64B 1.97 $2.20B N/A N/A

Arcadia Biosciences (RKDA) Competitors

$0.29 +0.00 (+1.48%)

As of 10/2/2026 04:00 PM Eastern

Compare

RKDA vs. KO, KOF, PEP, MNST, and CCEP

Should you buy Arcadia Biosciences stock or one of its competitors? Arcadia Biosciences's main competitors and comparable companies include CocaCola (KO), Coca Cola Femsa (KOF), PepsiCo (PEP), Monster Beverage (MNST), and Coca-Cola Europacific Partners (CCEP). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "soft drinks & non-alcoholic beverages" industry.

How does Arcadia Biosciences compare to CocaCola?

Arcadia Biosciences (NASDAQ:RKDA) and CocaCola (NYSE:KO) are both consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional ownership, profitability, analyst recommendations, valuation and media sentiment.

CocaCola has higher revenue and earnings than Arcadia Biosciences. Arcadia Biosciences is trading at a lower price-to-earnings ratio than CocaCola, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Arcadia Biosciences	$4.75M	0.15	-$2.34M	-$4.56	N/A
CocaCola	$47.94B	7.68	$13.11B	$3.33	25.70

CocaCola has a net margin of 28.56% compared to Arcadia Biosciences' net margin of -234.53%. CocaCola's return on equity of 39.38% beat Arcadia Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Arcadia Biosciences	-234.53%	-183.50%	-91.25%
CocaCola	28.56%	39.38%	13.18%

CocaCola has a consensus target price of $96.18, indicating a potential upside of 12.38%. Given CocaCola's stronger consensus rating and higher probable upside, analysts plainly believe CocaCola is more favorable than Arcadia Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Arcadia Biosciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
CocaCola	0 Sell rating(s)	2 Hold rating(s)	20 Buy rating(s)	1 Strong Buy rating(s)	2.96

Arcadia Biosciences has a beta of 0.56, indicating that its stock price is 44% less volatile than the broader market. Comparatively, CocaCola has a beta of 0.32, indicating that its stock price is 68% less volatile than the broader market.

In the previous week, CocaCola had 39 more articles in the media than Arcadia Biosciences. MarketBeat recorded 40 mentions for CocaCola and 1 mentions for Arcadia Biosciences. Arcadia Biosciences' average media sentiment score of 0.49 beat CocaCola's score of 0.32 indicating that Arcadia Biosciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Arcadia Biosciences	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CocaCola	11 Very Positive mention(s)	10 Positive mention(s)	10 Neutral mention(s)	4 Negative mention(s)	3 Very Negative mention(s)	Neutral

17.7% of Arcadia Biosciences shares are owned by institutional investors. Comparatively, 70.3% of CocaCola shares are owned by institutional investors. 4.5% of Arcadia Biosciences shares are owned by company insiders. Comparatively, 0.9% of CocaCola shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

CocaCola beats Arcadia Biosciences on 14 of the 17 factors compared between the two stocks.

How does Arcadia Biosciences compare to Coca Cola Femsa?

Coca Cola Femsa (NYSE:KOF) and Arcadia Biosciences (NASDAQ:RKDA) are both consumer staples companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

Coca Cola Femsa has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market. Comparatively, Arcadia Biosciences has a beta of 0.56, meaning that its stock price is 44% less volatile than the broader market.

Coca Cola Femsa has higher revenue and earnings than Arcadia Biosciences. Arcadia Biosciences is trading at a lower price-to-earnings ratio than Coca Cola Femsa, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Coca Cola Femsa	$15.22B	11.77	$1.32B	$6.34	16.81
Arcadia Biosciences	$4.75M	0.15	-$2.34M	-$4.56	N/A

Coca Cola Femsa has a net margin of 8.05% compared to Arcadia Biosciences' net margin of -234.53%. Coca Cola Femsa's return on equity of 15.83% beat Arcadia Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Coca Cola Femsa	8.05%	15.83%	7.32%
Arcadia Biosciences	-234.53%	-183.50%	-91.25%

Coca Cola Femsa currently has a consensus target price of $118.83, indicating a potential upside of 11.48%. Given Coca Cola Femsa's stronger consensus rating and higher possible upside, research analysts plainly believe Coca Cola Femsa is more favorable than Arcadia Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Coca Cola Femsa	0 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.44
Arcadia Biosciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

17.7% of Arcadia Biosciences shares are held by institutional investors. 1.0% of Coca Cola Femsa shares are held by insiders. Comparatively, 4.5% of Arcadia Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Coca Cola Femsa had 3 more articles in the media than Arcadia Biosciences. MarketBeat recorded 4 mentions for Coca Cola Femsa and 1 mentions for Arcadia Biosciences. Arcadia Biosciences' average media sentiment score of 0.49 beat Coca Cola Femsa's score of -0.02 indicating that Arcadia Biosciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Coca Cola Femsa	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Arcadia Biosciences	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Coca Cola Femsa beats Arcadia Biosciences on 12 of the 16 factors compared between the two stocks.

How does Arcadia Biosciences compare to PepsiCo?

Arcadia Biosciences (NASDAQ:RKDA) and PepsiCo (NASDAQ:PEP) are both consumer staples companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, media sentiment, institutional ownership, analyst recommendations, dividends and risk.

17.7% of Arcadia Biosciences shares are owned by institutional investors. Comparatively, 73.1% of PepsiCo shares are owned by institutional investors. 4.5% of Arcadia Biosciences shares are owned by company insiders. Comparatively, 0.1% of PepsiCo shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Arcadia Biosciences has a beta of 0.56, indicating that its share price is 44% less volatile than the broader market. Comparatively, PepsiCo has a beta of 0.35, indicating that its share price is 65% less volatile than the broader market.

PepsiCo has a net margin of 10.78% compared to Arcadia Biosciences' net margin of -234.53%. PepsiCo's return on equity of 54.63% beat Arcadia Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Arcadia Biosciences	-234.53%	-183.50%	-91.25%
PepsiCo	10.78%	54.63%	10.49%

In the previous week, PepsiCo had 68 more articles in the media than Arcadia Biosciences. MarketBeat recorded 69 mentions for PepsiCo and 1 mentions for Arcadia Biosciences. Arcadia Biosciences' average media sentiment score of 0.49 beat PepsiCo's score of 0.01 indicating that Arcadia Biosciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Arcadia Biosciences	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
PepsiCo	22 Very Positive mention(s)	8 Positive mention(s)	16 Neutral mention(s)	14 Negative mention(s)	6 Very Negative mention(s)	Neutral

PepsiCo has a consensus price target of $151.00, indicating a potential upside of 19.95%. Given PepsiCo's stronger consensus rating and higher probable upside, analysts plainly believe PepsiCo is more favorable than Arcadia Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Arcadia Biosciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
PepsiCo	1 Sell rating(s)	14 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.20

PepsiCo has higher revenue and earnings than Arcadia Biosciences. Arcadia Biosciences is trading at a lower price-to-earnings ratio than PepsiCo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Arcadia Biosciences	$4.75M	0.15	-$2.34M	-$4.56	N/A
PepsiCo	$96.90B	1.77	$8.24B	$7.63	16.50

Summary

PepsiCo beats Arcadia Biosciences on 13 of the 16 factors compared between the two stocks.

How does Arcadia Biosciences compare to Monster Beverage?

Monster Beverage (NASDAQ:MNST) and Arcadia Biosciences (NASDAQ:RKDA) are both consumer staples companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends, media sentiment and risk.

Monster Beverage has a net margin of 23.08% compared to Arcadia Biosciences' net margin of -234.53%. Monster Beverage's return on equity of 26.02% beat Arcadia Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Monster Beverage	23.08%	26.02%	21.21%
Arcadia Biosciences	-234.53%	-183.50%	-91.25%

72.4% of Monster Beverage shares are owned by institutional investors. Comparatively, 17.7% of Arcadia Biosciences shares are owned by institutional investors. 8.1% of Monster Beverage shares are owned by insiders. Comparatively, 4.5% of Arcadia Biosciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Monster Beverage has higher revenue and earnings than Arcadia Biosciences. Arcadia Biosciences is trading at a lower price-to-earnings ratio than Monster Beverage, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Monster Beverage	$8.29B	10.14	$1.91B	$1.08	39.76
Arcadia Biosciences	$4.75M	0.15	-$2.34M	-$4.56	N/A

In the previous week, Monster Beverage had 8 more articles in the media than Arcadia Biosciences. MarketBeat recorded 9 mentions for Monster Beverage and 1 mentions for Arcadia Biosciences. Arcadia Biosciences' average media sentiment score of 0.49 beat Monster Beverage's score of 0.40 indicating that Arcadia Biosciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Monster Beverage	3 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Arcadia Biosciences	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Monster Beverage currently has a consensus target price of $50.33, indicating a potential upside of 17.20%. Given Monster Beverage's stronger consensus rating and higher probable upside, analysts clearly believe Monster Beverage is more favorable than Arcadia Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Monster Beverage	0 Sell rating(s)	9 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.59
Arcadia Biosciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Monster Beverage has a beta of 0.49, indicating that its stock price is 51% less volatile than the broader market. Comparatively, Arcadia Biosciences has a beta of 0.56, indicating that its stock price is 44% less volatile than the broader market.

Summary

Monster Beverage beats Arcadia Biosciences on 14 of the 16 factors compared between the two stocks.

How does Arcadia Biosciences compare to Coca-Cola Europacific Partners?

Arcadia Biosciences (NASDAQ:RKDA) and Coca-Cola Europacific Partners (NASDAQ:CCEP) are both consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations, media sentiment and institutional ownership.

In the previous week, Coca-Cola Europacific Partners had 3 more articles in the media than Arcadia Biosciences. MarketBeat recorded 4 mentions for Coca-Cola Europacific Partners and 1 mentions for Arcadia Biosciences. Coca-Cola Europacific Partners' average media sentiment score of 0.53 beat Arcadia Biosciences' score of 0.49 indicating that Coca-Cola Europacific Partners is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Arcadia Biosciences	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Coca-Cola Europacific Partners	0 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Coca-Cola Europacific Partners has a consensus price target of $108.44, indicating a potential upside of 7.31%. Given Coca-Cola Europacific Partners' stronger consensus rating and higher possible upside, analysts clearly believe Coca-Cola Europacific Partners is more favorable than Arcadia Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Arcadia Biosciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Coca-Cola Europacific Partners	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.64

Coca-Cola Europacific Partners has higher revenue and earnings than Arcadia Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Arcadia Biosciences	$4.75M	0.15	-$2.34M	-$4.56	N/A
Coca-Cola Europacific Partners	$23.64B	1.97	$2.20B	N/A	N/A

Arcadia Biosciences has a beta of 0.56, meaning that its share price is 44% less volatile than the broader market. Comparatively, Coca-Cola Europacific Partners has a beta of 0.51, meaning that its share price is 49% less volatile than the broader market.

17.7% of Arcadia Biosciences shares are owned by institutional investors. Comparatively, 31.4% of Coca-Cola Europacific Partners shares are owned by institutional investors. 4.5% of Arcadia Biosciences shares are owned by insiders. Comparatively, 3.0% of Coca-Cola Europacific Partners shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Coca-Cola Europacific Partners has a net margin of 0.00% compared to Arcadia Biosciences' net margin of -234.53%. Coca-Cola Europacific Partners' return on equity of 0.00% beat Arcadia Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Arcadia Biosciences	-234.53%	-183.50%	-91.25%
Coca-Cola Europacific Partners	N/A	N/A	N/A

Summary

Coca-Cola Europacific Partners beats Arcadia Biosciences on 13 of the 15 factors compared between the two stocks.

Get Arcadia Biosciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RKDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RKDA vs. The Competition

Export

Metric	Arcadia Biosciences	Beverages Industry	Consumer Staples Sector	NASDAQ Exchange
Market Cap	$684K	$22.09B	$15.26B	$13.18B
Dividend Yield	N/A	2.75%	3.33%	16.78%
P/E Ratio	-0.06	16.86	13.97	26.04
Price / Sales	0.15	29.51	264,296.88	108.79
Price / Cash	0.22	17.35	57.01	51.75
Price / Book	0.12	3.68	4.14	6.31
Net Income	-$2.34M	$905.81M	$842.01M	$362.16M
7 Day Performance	-6.31%	-2.08%	-1.97%	-1.66%
1 Month Performance	-38.88%	-5.77%	-5.09%	-4.50%
1 Year Performance	-91.69%	-8.64%	7.45%	2.06%

Arcadia Biosciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RKDA Arcadia Biosciences	1.0624 of 5 stars	$0.29 +1.5%	N/A	-91.7%	$684K	$4.75M	N/A	60	Short Interest Decrease Gap Down
KO CocaCola	4.5221 of 5 stars	$88.07 -0.6%	$95.76 +8.7%	+29.5%	$378.91B	$47.94B	26.45	65,900
KOF Coca Cola Femsa	3.6262 of 5 stars	$110.35 -1.4%	$118.83 +7.7%	+29.7%	$185.46B	$15.22B	17.41	108,840	Dividend Cut
PEP PepsiCo	4.489 of 5 stars	$130.18 -0.8%	$156.80 +20.4%	-11.5%	$177.68B	$93.93B	17.06	306,000	Trending News Upcoming Earnings Analyst Downgrade
MNST Monster Beverage	3.1523 of 5 stars	$43.91 -0.8%	$50.33 +14.6%	+27.1%	$86.02B	$8.29B	40.66	6,891

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RKDA) was last updated on 10/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Arcadia Biosciences (RKDA) Competitors

RKDA vs. KO, KOF, PEP, MNST, and CCEP

How does Arcadia Biosciences compare to CocaCola?

Summary

How does Arcadia Biosciences compare to Coca Cola Femsa?

Summary

How does Arcadia Biosciences compare to PepsiCo?

Summary

How does Arcadia Biosciences compare to Monster Beverage?

Summary

How does Arcadia Biosciences compare to Coca-Cola Europacific Partners?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RKDA vs. The Competition

Arcadia Biosciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Arcadia Biosciences (RKDA) Competitors

RKDA vs. KO, KOF, PEP, MNST, and CCEP

How does Arcadia Biosciences compare to CocaCola?

Which has stronger earnings and valuation, RKDA or KO?

Is RKDA or KO more profitable?

Do analysts recommend RKDA or KO?

Which has more risk & volatility, RKDA or KO?

Does the media favor RKDA or KO?

Do insiders and institutionals believe in RKDA or KO?

Summary

How does Arcadia Biosciences compare to Coca Cola Femsa?

Which has more volatility & risk, KOF or RKDA?

Which has preferable valuation and earnings, KOF or RKDA?

Is KOF or RKDA more profitable?

Do analysts rate KOF or RKDA?

Do institutionals and insiders have more ownership in KOF or RKDA?

Does the media refer more to KOF or RKDA?

Summary

How does Arcadia Biosciences compare to PepsiCo?

Do institutionals & insiders believe in RKDA or PEP?

Which has more volatility & risk, RKDA or PEP?

Is RKDA or PEP more profitable?

Does the media refer more to RKDA or PEP?

Do analysts recommend RKDA or PEP?

Which has preferable valuation & earnings, RKDA or PEP?

Summary

How does Arcadia Biosciences compare to Monster Beverage?

Is MNST or RKDA more profitable?

Do insiders & institutionals believe in MNST or RKDA?

Which has stronger valuation and earnings, MNST or RKDA?

Does the media refer more to MNST or RKDA?

Do analysts prefer MNST or RKDA?

Which has more risk and volatility, MNST or RKDA?

Summary

How does Arcadia Biosciences compare to Coca-Cola Europacific Partners?

Does the media favor RKDA or CCEP?

Do analysts prefer RKDA or CCEP?

Which has preferable earnings & valuation, RKDA or CCEP?

Which has more volatility and risk, RKDA or CCEP?

Do institutionals and insiders have more ownership in RKDA or CCEP?

Is RKDA or CCEP more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RKDA vs. The Competition

Arcadia Biosciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools